Skip to main content
logo
Genix Pharmaceuticals Corporation (TSXV:GENX)
Canada flag Canada · Delayed Price · Currency is CAD
0.0200
0.00 (0.00%)
At close: Aug 21, 2026

Genix Pharmaceuticals Ratios and Metrics

Millions CAD. Fiscal year is Nov - Oct.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Market Capitalization
123249
Market Cap Growth
-31.08%-37.97%25.00%-38.46%-56.67%-9.37%
Enterprise Value
234349
Last Close Price
0.020.030.050.040.070.15

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
PS Ratio
--730.98191.87--
PB Ratio
-0.79-1.29-2.50-2.081.202.21

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
EV/Sales Ratio
--910.96225.59--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Debt / Equity Ratio
-0.74-0.73-0.69-0.450.060.01
Net Debt / Equity Ratio
-0.74-0.70-0.68-0.440.05-0.02
Net Debt / EBITDA Ratio
--8.01-2.22-1.75-0.380.08
Net Debt / FCF Ratio
-12.01-8.05-4.29-2.26-0.790.21
Asset Turnover
--0.030.01--
Inventory Turnover
---0.06--
Quick Ratio
0.010.030.010.010.020.19
Current Ratio
0.020.040.030.160.230.25
Return on Equity (ROE)
----426.41%-29.78%-37.25%
Return on Assets (ROA)
-177.39%-163.11%-169.16%-23.23%-13.83%-19.90%
Return on Capital Employed (ROCE)
6.90%8.90%30.80%73.10%-31.20%-40.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Earnings Yield
-24.98%-18.24%-2.47%-185.55%-27.90%-18.60%
FCF Yield
-7.77%-6.75%-6.33%-9.31%-5.70%-4.82%
Buyback Yield / Dilution
-2.23%-0.54%----18.55%